Neurologists from Lleida to present their research in the field of stroke in Germany

The Neurology Service of the Arnau de Vilanova University Hospital in Lleida together with the Clinical Neurosciences group of the Institute for Research in Biomedicine (IRBLleida) and the University of Lleida have actively participated in the international congress of the European Stroke Organization, held in Munich from 24 to 26 May, presenting their research work.

Specifically, 8 communications have been presented related to affective and cognitive alterations after a stroke, the long-term prognosis after more than 5 years of evolution of patients with transient stroke, the use of lipidomics and metabolomics techniques to find plasma biomarkers of aetiology and prognosis in patients with intracranial haemorrhages, the beneficial effect of vaccines on the risk of stroke in patients with COVID-19 infection and the development of an animal (mouse) model of stroke to understand the phenomenon of remote ischaemic tolerance.

In addition, the group has coordinated a scientific session on the beneficial effects of remote ischaemic tolerance in patients with ischaemic stroke. Remote ischaemic tolerance is the phenomenon whereby stimuli on the extremities by means of compression and decompression cycles activate endogenous mechanisms specific to each person that mitigate the effect of cerebral ischaemia. This session allowed the experience of leading groups in Europe and the United States to be shared.